Literature DB >> 8101419

2-Chloro-2' deoxyadenosine prevents angiopathic changes in cerebral arteries in experimental SAH in rabbits.

M Ryba1, P Grieb, M Walski, J Sawicki, M Pastuszko.   

Abstract

We compared the morphology of the basilar artery walls in rabbits with experimental subarachnoid haemorrhage (SAH) without and with concomitant treatment with a novel immunosuppressive drug, 2-chloro-2'-deoxyadenosine (2 CdA). The treatment was successful in the prevention of the angiopathic changes, most likely due to its ability to inhibit lymphocyte activation in response to mitogenic signals. Since lymphocyte (and monocyte?) activation may play an important role in the development of the delayed neurological deficits in patients following SAH, the use of 2 CdA to prevent these deficits shall be considered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101419     DOI: 10.1007/bf01446997

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

1.  Cyclosporine A for the prevention of neurological deficit following subarachnoid hemorrhage.

Authors:  M Ryba; P Grieb; J Bidzinski; M Pastuszko; C Dziewiecki; K Iwanska
Journal:  Stroke       Date:  1991-04       Impact factor: 7.914

Review 2.  Cyclosporine.

Authors:  B D Kahan
Journal:  N Engl J Med       Date:  1989-12-21       Impact factor: 91.245

3.  2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.

Authors:  E Beutler; L D Piro; A Saven; A C Kay; R McMillan; R Longmire; C J Carrera; P Morin; D A Carson
Journal:  Leuk Lymphoma       Date:  1991

4.  Intracranial arterial spasm: a clinical analysis.

Authors:  R H Wilkins; J A Alexander; G L Odom
Journal:  J Neurosurg       Date:  1968-08       Impact factor: 5.115

5.  [Immunological study of late cerebral vasospasm in subarachnoid hemorrhage. Detection of immunoglobulins, C3, and fibrinogen in cerebral arterial walls by immunofluorescence method].

Authors:  T Hoshi; T Shimizu; K Kito; N Yamasaki; K Takahashi; M Takahashi; T Okada; H Kasuya; K Kitamura
Journal:  Neurol Med Chir (Tokyo)       Date:  1984-09       Impact factor: 1.742

6.  Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.

Authors:  C J Carrera; C Terai; M Lotz; J G Curd; L D Piro; E Beutler; D A Carson
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Is vascular angiopathy following intracranial aneurysm rupture immunologically mediated?

Authors:  M Ryba; M Jarzabek-Chorzelska; T Chorzelski; M Pastuszko
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

8.  Cyclosporine A reduces cerebral vasospasm after subarachnoid hemorrhage in dogs.

Authors:  J W Peterson; S Nishizawa; J D Hackett; T Bun; A Teramura; N T Zervas
Journal:  Stroke       Date:  1990-01       Impact factor: 7.914

9.  The angiopathy of subarachnoid hemorrhage: angiographic and morphologic correlates.

Authors:  R R Smith; B R Clower; D F Peeler; J Yoshioka
Journal:  Stroke       Date:  1983 Mar-Apr       Impact factor: 7.914

10.  Cerebral artery spasm. A histological study at necropsy of the blood vessels in cases of subarachnoid hemorrhage.

Authors:  J T Hughes; P M Schianchi
Journal:  J Neurosurg       Date:  1978-04       Impact factor: 5.115

View more
  2 in total

1.  Successful prevention of neurological deficit in SAH patients with 2-chlorodeoxyadenosine.

Authors:  M Ryba; P Grieb; M Pastuszko; J Bidziński; J Andrychowski; C Dziewiecki; P Bojarski; L Królicki
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

2.  Delayed Cerebral Ischemia After Subarachnoid Hemorrhage: Experimental-Clinical Disconnect and the Unmet Need.

Authors:  Fumiaki Oka; David Y Chung; Michiyasu Suzuki; Cenk Ayata
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.